Extracorporeal membrane oxygenation as a bridge to lung transplantation may not impact overall mortality risk after transplantation: Results from a 7-year single-centre experience
European Journal of Cardio-Thoracic Surgery Feb 16, 2018
Ius F, et al. - Researchers, in this study, report their experience with pretransplant extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation during the last 7 years and investigated its impact on graft outcomes. They identify that pretransplant ECMO as a bridge to transplantation, if applied in selected patients, results in impaired, but still high in-hospital, survival and does not impact graft survival.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries